Quick Answer
Amphastar Pharmaceuticals, Inc. reported Total Assets of $1.63 billion for fiscal year 2025.
Amphastar Pharmaceuticals, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $1.63B | +3.3% |
| 2024 | $1.58B | +4.3% |
| 2023 | $1.51B | +103.9% |
| 2022 | $741.99M | +10.5% |
| 2021 | $671.53M | +6.4% |
| 2020 | $631.24M | +7.5% |
| 2019 | $586.97M | +14.3% |
| 2018 | $513.56M | +13.9% |
| 2017 | $451.07M | +5.5% |
| 2016 | $427.74M | +9.6% |
| 2015 | $390.14M | +0.2% |
| 2014 | $389.37M | +14.9% |
| 2013 | $338.75M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.67B | +7.8% | +3.2% |
| June 30, 2025 | $1.62B | +8.3% | -0.7% |
| March 31, 2025 | $1.63B | +3.3% | +3.1% |
| December 31, 2024 | $1.58B | +4.3% | +2.1% |
| September 30, 2024 | $1.55B | +0.0% | +3.6% |
| June 30, 2024 | $1.49B | +8.2% | -5.3% |
| March 31, 2024 | $1.57B | +103.5% | +4.1% |
| December 31, 2023 | $1.51B | +103.9% | -2.1% |
- Amphastar Pharmaceuticals, Inc. showed an increase of +3.3% in Total Assets compared to the prior fiscal year.
- Over the 2013–2025 period, Amphastar Pharmaceuticals, Inc.’s total assets has grown by 381.0% (from $338.75 million to $1.63 billion).
- The most recent figure is from Amphastar Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: